Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stated that, subsequent to an autonomous DSMB recommendation and also following futility assessment, it has halted the Phase II HERMIONE trial of “MM-302” in people suffering with +HER2 metastatic breast cancer, but had initially been on regimen of pertuzumab, trastuzumab and ado-trastuzumab emtansine. The buzz The decision...
Although a tremendous progress has been made, large full-thickness skin defects are still associated with mortality due to a low availability of donor skin areas. Autologous cultured epidermal autografts (CEA) were first to be used as an epidermal substitute; however, their functional and esthetic results were unsatisfying due to graft...
Before we get into specifics of GNCM, in an exciting series of events aimed at building shareholder value, Pure Hospitality Solution, Inc. (OTCMKTS:PNOW), the creator of Oveedia and the quickly growing Numismatic Specialty Store, Meso Numismatics, announced that the company will award shareholders with a very generous preferred stock...
Aducanumab, a clinical treatment drug, primed to treat those with early symptoms of Alzheimer’s, recently went into Phase 1B clinical studies trial. Recently, the firm responsible for the manufacturing of the clinical treatment drugs, Biogen Inc. (NASDAQ:BIIB) released the data obtained from the Phase 1B trial. The data will be...
The stock price of Conatus Pharmaceuticals Inc (NASDAQ:CNAT) are moving north on the chart since last few days. Recent NASH play has finally rewarded firm’s shareholders. The biotech concern has made a transformational collaboration agreement with drug giant company Novartis AG (ADR)(NYSE:NVS) about its compound emricasan. The biotech industry continues...
Merck & Co., Inc. (NYSE:MRK) Zovastak, the shingles vaccine developed by Merck has increasingly come under a wave of lawsuits following claims that it is causing serious injury and sometimes even death. Plaintiffs in the lawsuits are now suing Merck for not warning them of the vaccine’s severe side...
Altimmune Inc (NASDAQ:ALT) is a company that focuses in the manufacture of vaccines. The business guru says it will expand its business presence in Gatihersburg and this is a major addition to the fast rising bio-technology industry in Montgomery County. A close outlook The company believes that the new 14,000 square foot...
There are 30.1 million Americans with diabetes, 380 million worldwide means a vast, wide-open market. It’s a public health crisis like few others – 9.4% of Americans have diabetes. And, the drug that keeps them alive – insulin – is made by just three multinational corporations. In fact, 3 pharmaceutical giants...
Before we go into details of Delcath Systems, Inc. (NASDAQ:DCTH), a biotech company that needs your immediate attention is OncBioMune Pharmaceuticals Inc (OTCMKTS:OBMP). OBMP is a clinical stage biopharmaceutical company that develops cancer immunotherapy products. The company has proprietary rights to a breast and prostate patent vaccine; and a process...
Galena Biopharma Inc (NASDAQ:GALE) a biopharmaceutical firm committed to the advancement and commercialization of hematology as well as oncology therapeutics issued the report from a meeting of the DSMB for the two IST combination clinical studies with NeuVax™ plus trastuzumab. The studies are being carried out in breast cancer...